We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

503 hedge funds and large institutions have $1.47B invested in iShares US Medical Devices ETF in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 128 increasing their positions, 198 reducing their positions, and 84 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more call options, than puts

Call options by funds: $7.69M | Put options by funds: $4.85M

3.7% more ownership

Funds ownership: 42.18%45.88% (+3.7%)

9% less funds holding

Funds holding: 553503 (-50)

15% less capital invested

Capital invested by funds: $1.73B → $1.47B (-$260M)

35% less repeat investments, than reductions

Existing positions increased: 128 | Existing positions reduced: 198

44% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 84

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
503
Holders Change
-50
Holders Change %
-9.04%
% of All Funds
6.19%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.02%
New
47
Increased
128
Reduced
198
Closed
84
Calls
$7.69M
Puts
$4.85M
Net Calls
+$2.84M
Net Calls Change
-$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
OSAM
301
O'Shaughnessy Asset Management
Connecticut
$308K +$8.69K +148 +3%
SVWAG
302
Sound View Wealth Advisors Group
Georgia
$305K +$2.76K +47 +0.8%
CIC
303
Cutler Investment Counsel
Oregon
$303K -$7.05K -120 -2%
CD
304
Capital Developers
North Carolina
$299K +$12K +204 +4%
FPGK
305
Financial Partners Group (Kansas)
Kansas
$298K -$19.9K -339 -6%
AFFA
306
ALM First Financial Advisors
Texas
$297K
SWA
307
Stratos Wealth Advisors
Ohio
$296K -$1.41M -24,051 -81%
SI
308
Stephens Inc
Arkansas
$296K -$82.2K -1,399 -20%
SFM
309
Signet Financial Management
New Jersey
$293K -$411 -7 -0.1%
AWA
310
Arkadios Wealth Advisors
Georgia
$292K -$7.28K -124 -2%
GIA
311
Gladstone Institutional Advisory
Florida
$292K +$18K +307 +6%
USCWA
312
U.S. Capital Wealth Advisors
Texas
$292K +$78.7K +1,341 +32%
MAC
313
Mason & Associates (California)
California
$288K +$31.3K +533 +11%
AAM
314
Aureus Asset Management
Massachusetts
$288K +$317K +5,400 New
CFA
315
Cahill Financial Advisors
Minnesota
$283K +$117 +2 +0%
CWMK
316
Caliber Wealth Management (Kansas)
Kansas
$279K -$4.93K -84 -2%
LG
317
LaFleur & Godfrey
Michigan
$277K +$9.92K +169 +3%
SG
318
StoneX Group
New York
$274K -$42.8K -728 -12%
IMC Chicago
319
IMC Chicago
Illinois
$270K -$507K -8,627 -63%
FFS
320
Founders Financial Securities
Maryland
$267K -$8.81K -150 -3%
WANY
321
Wealthspire Advisors (New York)
New York
$267K +$21.2K +361 +8%
GVAG
322
Great Valley Advisor Group
Delaware
$265K
C1AG
323
Client 1st Advisory Group
Florida
$264K -$34.9K -594 -11%
CCA
324
Carrera Capital Advisors
Michigan
$264K +$59 +1 +0%
SC
325
Savant Capital
Illinois
$262K -$21.1K -360 -7%

IHI Hedge Fund Activity: Q1 2026 in Review

503 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q1 2026, worth a combined $1.47B — down 15% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 84 funds closed out of IHI and 47 opened new positions — a net loss of 37 holders — while 198 trimmed existing stakes and 128 added.

The largest buyer was Citigroup, adding an estimated $103M. The largest seller was Menora Mivtachim Holdings, cutting an estimated $146M.

  • 503 institutional investors held iShares US Medical Devices ETF (IHI) as of Q1 2026, down from 553 in Q4 2025.
  • Funds reported $1.47B of iShares US Medical Devices ETF stock for Q1 2026, down 15% quarter-over-quarter.
  • 47 funds opened new iShares US Medical Devices ETF positions in Q1 2026 and 84 closed out, a net change of -37 holders.
  • The largest iShares US Medical Devices ETF buyer in Q1 2026 was Citigroup, an estimated $103M added.
  • The largest iShares US Medical Devices ETF seller in Q1 2026 was Menora Mivtachim Holdings, an estimated $146M sold.

Based on aggregated 13F filings for Q1 2026.